At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots.